Albumin Alters the Conformational Ensemble of Amyloid-β by Promiscuous Interactions: Implications for Amyloid Inhibition
Authors:
Open Access
- 23 February 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 7
Abstract
Human serum albumin (HSA) is a key endogenous inhibitor of amyloid-β (Αβ) aggregation. In vitro HSA inhibits Aβ fibrillization and targets multiple species along the aggregation pathway including monomers, oligomers, and protofibrils. Amyloid inhibition by HSA has both pathological implications and therapeutic potential, but the underlying molecular mechanism remains elusive. As a first step towards addressing this complex question, we studied the interactions of an Aβ42 monomer with HSA by molecular dynamics simulations. To adequately sample the conformational space, we adapted the replica exchange with solute tempering (REST2) method to selectively heat the Aβ42 peptide in the absence and presence of HSA. Aβ42 binds to multiple sites on HSA with a preference to domain III and adopts various conformations that all differ from the free state. The β-sheet abundances of H14-E22 and A30-M33 regions are significantly reduced by HSA, so are the β-sheet lengths. HSA shifts the conformational ensemble towards more disordered states and alters the β-sheet association patterns. In particular, the frequent association of Q15-V24 and N27-V36 regions into β-hairpin which is critical for aggregation is impeded. HSA primarily interacts with the latter β-region and the N-terminal charged residues. They form promiscuous interactions characterized by salt bridges at the edge of the peptide-protein interface and hydrophobic cores at the center. Consequently, intrapeptide interactions crucial for β-sheet formation are disrupted. Our work builds the bridge between the modification of Aβ conformational ensemble and amyloid inhibition by HSA. It also illustrates the potential of the REST2 method in studying interactions between intrinsically disordered peptides and globular proteins.Keywords
This publication has 69 references indexed in Scilit:
- A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR StudyAlzheimer's & Dementia, 2020
- Serum Albumin's Protective Inhibition of Amyloid-β Fiber Formation Is Suppressed by Cholesterol, Fatty Acids and WarfarinJournal of Molecular Biology, 2018
- Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril statesJournal of Biological Chemistry, 2017
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathwayJBIC Journal of Biological Inorganic Chemistry, 2014
- Mapping the Interactions between the Alzheimer’s Aβ-Peptide and Human Serum Albumin beyond Domain ResolutionBiophysical Journal, 2013
- Hamiltonian replica exchange in GROMACS: a flexible implementationMolecular Physics, 2013
- Amyloid β-Protein: Monomer Structure and Early Aggregation States of Aβ42 and Its Pro19AlloformJournal of the American Chemical Society, 2005
- Endogenous Proteins Controlling Amyloid β-Peptide PolymerizationJournal of Biological Chemistry, 1999
- 762 Aβ is transported on lipoproteins and albumin in human biological fluidsNeurobiology of Aging, 1996